Department of Intensive Care, Kuopio University Hospital
Kuopio, PL 1777, 70211, Finland
NCT Number: NCT00614887
Subarachnoid haemorrhage (SAH) may cause damage to the hypotalamo-pituitary-adrenal axis (HPA) thus disturbing the hormonal response of these structures.
The aim of our study is to characterize the function of HPA-axis acutely and over time up to three months in patients with SAH.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Kuopio, PL 1777, 70211, Finland
The hypotalamo-pituitary-adrenal (HPA)-axis may be affected in SAH by temporary or permanent damage to the hypothalamus and/or pituitary gland. Also surgery or endovascular treatment of a ruptured intracranial aneurysm may affect the hormonal response of the HPA-axis. Some data suggest a high incidence of delayed endocrine abnormalities in patients with SAH but only little data exists on the acute endocrine abnormalities in this disease.
We will study the pituitary-adrenal hormone levels in patients with acute aneurysmal SAH and patients admitted for elective cranial aneurysm surgery will serve as a control population. We will use serum free cortisol calculation and total cortisol measurements as well as adrenocorticotrophic hormone (ACTH) stimulation test in assessing the responsiveness of the adrenal gland to exogenous ACTH. The hormone levels will be measured repeatedly during the first seven days after SAH and once at three months.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
SAH-group:
Control group:
Exclusion criteria
SAH group:
control group:
Kuopio University Hospital
Other
Acronym: SAHENDO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00962546
Aneurysm, Brain Diseases
St Louis, Missouri, United States
View Trial DetailsNCT01919775
Amnesia, Aneurysm
View Trial DetailsNCT05961748
Aneurysm, Aortic Diseases
Beijing, Beijing Municipality, China
View Trial DetailsNCT04236856
Aneurysm, Brain Diseases
Southport, Queensland, Australia
View Trial Details